---
figid: PMC4001781__nihms570988f3
figlink: /pmc/articles/PMC4001781/figure/F3/
number: F3
caption: Multiple mechanisms of acquired BRAF inhibitor resistance have been identified.
  BRAF V600E melanoma cells chronically treated with BRAF inhibitors acquire drug
  resistance via switching between the three isoforms of RAF (ARAF, BRAF, CRAF) to
  activate the MAPK pathway. Increased IGFR1 and PDGFR signaling may also allow for
  resistance by activating PI3K/AKT signaling as well as other pathways. Resistance
  can also arise following the reactivation of the MAPK pathway, this can occur following
  the acquisition of activating mutations in NRAS (Q61K) and MEK (C121S) and the increased
  expression of the MAP3K8 (COT).
pmcid: PMC4001781
papertitle: Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant
  melanoma.
reftext: Inna V. Fedorenko, et al. Biochem Pharmacol. ;82(3):201-209.
pmc_ranked_result_index: '15138'
pathway_score: 0.9634164
filename: nihms570988f3.jpg
figtitle: Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma
year: ''
organisms:
- Homo sapiens
ndex: 143fa5df-ded4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4001781__nihms570988f3.html
  '@type': Dataset
  description: Multiple mechanisms of acquired BRAF inhibitor resistance have been
    identified. BRAF V600E melanoma cells chronically treated with BRAF inhibitors
    acquire drug resistance via switching between the three isoforms of RAF (ARAF,
    BRAF, CRAF) to activate the MAPK pathway. Increased IGFR1 and PDGFR signaling
    may also allow for resistance by activating PI3K/AKT signaling as well as other
    pathways. Resistance can also arise following the reactivation of the MAPK pathway,
    this can occur following the acquisition of activating mutations in NRAS (Q61K)
    and MEK (C121S) and the increased expression of the MAP3K8 (COT).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - BRAF
  - AKT1
  - PIK3R4
  - ARAF
  - MAPK3
  - MAP2K1
  - PIK3R3
  - AKT2
  - PIK3CD
  - PIK3CG
  - PIK3CB
  - CROT
  - PIK3R5
  - RAF1
  - MAP2K2
  - PIK3R6
  - PIK3CA
  - AKT3
  - PDGFRB
  - NRAS
  - Cancer
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: ARAF
  symbol: ARAF
  source: hgnc_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: COT
  symbol: COT
  source: hgnc_alias_symbol
  hgnc_symbol: CROT
  entrez: '54677'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: CRAF
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PDGFRB
  symbol: PDGFRB
  source: hgnc_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: NRAS
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4001781__F3
redirect_from: /figures/PMC4001781__F3
figtype: Figure
---
